| Literature DB >> 31114767 |
Sarah C Titman1, Stephen C Radley2, Thomas G Gray2.
Abstract
The objective of this review is to present and discuss up-to-date conservative treatment strategies for the management of stress urinary incontinence (SUI) in women. This review aims to provide an overview of the importance of initial self-management strategies and conservative management options for women with SUI and how these treatments can be integrated into clinical practice. The various treatment modalities available including pelvic floor physiotherapy, biofeedback, and neuromuscular electrical stimulation devices, in addition to lifestyle changes which can significantly affect symptoms, are discussed. The relevance and importance of individual assessment and training programs is highlighted in addition to additional adjuncts available to facilitate rehabilitation and symptom improvement. Expected outcomes for women with mild to moderate SUI who participate in targeted individualized conservative management programs are generally good, with a high likelihood of substantial improvement in symptoms.Entities:
Keywords: pelvic floor disorders; physical therapy modalities; stress; urinary incontinence
Year: 2019 PMID: 31114767 PMCID: PMC6489641 DOI: 10.2147/RRU.S177826
Source DB: PubMed Journal: Res Rep Urol ISSN: 2253-2447
Summary of guidelines for self-management of SUI included in review
| Author | Year published | Review summary | Findings | Limitations |
|---|---|---|---|---|
| Castro et al | 2008 | Single blind RCT | Continence specific outcome measure used in addition to a quality of life Likert score (ranging 0–100). | Participants had confirmed urodynamic SUI, which is not always reflective of patients receiving first-line treatment. |
| Dumoulin et al | 2018 | Cochrane review comparing PFMT to no treatment. | SUI eight times more likely to improve with PFMT than no treatment. | High variables in PFM training programs within studies included. |
| Haysmith et al | 2011 | Cochrane review of different approaches to PFMT. | Subjective improvements in outcomes found with active treatment arms, with more improvement with regular professional contact in both group and individual supervision. | Wide variety of methodological differences between included studies. |
| Herbison et al | 2002 | Cochrane review | Limited evidence to support the use of cones for SUI management however not considered superior to PFMT or electrical stimulation as alternative treatment modalities. | Different outcome measures used and a lack of quality of life outcome measures implemented by studies. |
| Moroni et al | 2016 | Systematic literature review | Evidence to support the use of PFMT with or without biofeedback training with positive subjective outcomes. | Large variations between interventions within studies. |
Abbreviations: SUI, stress urinary incontinence; RCT, randomized controlled trial; PFMT, pelvic floor muscle training; PFM pelvic floor muscle.
Modified Oxford grading score
| Numerical scale | Evaluation of strength |
|---|---|
| 0 | No contraction |
| 1 | Flicker |
| 2 | Weak |
| 3 | Moderate |
| 4 | Good (with lift) |
| 5 | Strong |
PERFECT score26
| P | Power | Strength of MVC, measured by the modified Oxford grading (0–5) |
|---|---|---|
| E | Endurance | Length of MVC (before strength is reduced by 35% or more) |
| R | Repetitions | Repetition of endurance hold |
| F | Fast contractions | Number of fast contractions |
| ECT | Every, Contraction, Timed |
Abbreviation: MVC, maximal voluntary contraction.
Figure 1Neen PeritoneTM Biofeedback device used to provide biofeedback on the effectiveness of pelvic floor muscle activation.
Figure 2Neen PericalmTM neuro-muscular electrical stimulation kit.
Note: The probe on the right is inserted into the vagina and provides electrical stimulation to provoke pelvic floor muscle contraction to aid power and contractility of the pelvic floor as part of a pelvic floor muscle training regime.
Figure 3An example of two of the many intravaginal devices designed to reduce stress urinary incontinence. ContiformTM (left) UrestaTM (right).
Note: ContiformTM (left); UrestaTM (right).